• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化因子VII的荧光测定。日本人血浆中因子VIIa水平与动脉心血管疾病的关系。

Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.

作者信息

Kario K, Miyata T, Sakata T, Matsuo T, Kato H

机构信息

Hyogo Prefectural Awaji Hospital, Japan.

出版信息

Arterioscler Thromb. 1994 Feb;14(2):265-74. doi: 10.1161/01.atv.14.2.265.

DOI:10.1161/01.atv.14.2.265
PMID:8305419
Abstract

Factor VII (FVII) plays an important role in initiation of the tissue factor-induced coagulation pathway. An increase in FVII coagulant activity (FVIIc) has been proposed as an independent risk factor for coronary artery disease. However, it remains uncertain whether high FVIIc levels are due to an increase in the activation of FVII or an increase in the concentration of FVII mass. We developed a new fluorogenic assay for plasma activated FVII (FVIIa) that used soluble tissue factor. The sensitivity of this assay ranged from 0.2 to 1000 ng FVIIa per milliliter of plasma. Plasma FVIIa levels were measured in 110 healthy subjects and 93 patients with hypertension, diabetes mellitus, and/or cardiovascular disease. The mean plasma FVIIa level in healthy Japanese individuals was 2.5 ng/mL, which was lower than that in Western subjects. Gel filtration analysis showed that most of the circulating FVIIa was in a free form, and binding of FVIIa to tissue factor in plasma was not detected. Aging increased both the FVIIa level and FVII mass, whereas menopause increased mainly the FVII mass. Elderly patients with arterial cardiovascular diseases showed increases in plasma FVIIa levels and FVIIa to FVII antigen (FVII:Ag) ratios. Among the elderly, arterial cardiovascular disease was more common in a high-FVIIa than a low-FVIIa group. Plasma FVIIa levels were not correlated with serum levels of total cholesterol or triglycerides. The FVIIa level and the FVIIa-to-FVII:Ag ratio were positively correlated with fibrinogen level and negatively correlated with body mass index and serum albumin level in the elderly. In conclusion, aging, cardiovascular disease, and malnutrition increased plasma FVIIa levels. FVIIa levels were not correlated with lipid levels or hepatic synthesis, suggesting that FVIIa may be an independent risk factor for cardiovascular disease.

摘要

凝血因子VII(FVII)在组织因子诱导的凝血途径启动过程中发挥重要作用。FVII凝血活性(FVIIc)升高已被认为是冠状动脉疾病的独立危险因素。然而,FVIIc水平升高是由于FVII激活增加还是FVII质量浓度增加仍不确定。我们开发了一种用于血浆活化FVII(FVIIa)的新型荧光测定法,该方法使用可溶性组织因子。该测定法的灵敏度范围为每毫升血浆0.2至1000 ng FVIIa。对110名健康受试者和93名患有高血压、糖尿病和/或心血管疾病的患者进行了血浆FVIIa水平测定。健康日本个体的平均血浆FVIIa水平为2.5 ng/mL,低于西方受试者。凝胶过滤分析表明,大多数循环中的FVIIa呈游离形式,未检测到血浆中FVIIa与组织因子的结合。衰老会使FVIIa水平和FVII质量均升高,而绝经主要使FVII质量增加。患有动脉心血管疾病的老年患者血浆FVIIa水平及FVIIa与FVII抗原(FVII:Ag)的比值升高。在老年人中,高FVIIa组比低FVIIa组动脉心血管疾病更常见。血浆FVIIa水平与血清总胆固醇或甘油三酯水平无关。在老年人中,FVIIa水平及FVIIa与FVII:Ag的比值与纤维蛋白原水平呈正相关,与体重指数和血清白蛋白水平呈负相关。总之,衰老、心血管疾病和营养不良会使血浆FVIIa水平升高。FVIIa水平与血脂水平或肝脏合成无关,提示FVIIa可能是心血管疾病的独立危险因素。

相似文献

1
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.活化因子VII的荧光测定。日本人血浆中因子VIIa水平与动脉心血管疾病的关系。
Arterioscler Thromb. 1994 Feb;14(2):265-74. doi: 10.1161/01.atv.14.2.265.
2
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.凝血因子VII与人群的相关性。年龄、性别和绝经状态作为活化因子VII决定因素的重要性。
Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1170-6. doi: 10.1161/01.atv.16.9.1170.
3
The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.使用牛凝血活酶的凝血因子VII凝血活性与活化凝血因子VII水平之间存在强正相关。
Thromb Haemost. 1995 Mar;73(3):429-34.
4
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease].[活化凝血因子VII作为动脉粥样硬化血栓形成疾病的一种新的心血管危险因素]
Rinsho Byori. 1995 Dec;43(12):1201-8.
5
Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.健康个体及凝血酶原复合物浓缩物中因子VII及活化因子VII的测定
Thromb Res. 1997 Jun 15;86(6):493-504. doi: 10.1016/s0049-3848(97)00098-4.
6
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Arterioscler Thromb Vasc Biol. 1995 May;15(5):655-64. doi: 10.1161/01.atv.15.5.655.
7
Genetic determinants of plasma factor VII activity in the Japanese.日本人血浆凝血因子VII活性的遗传决定因素
Thromb Haemost. 1995 Apr;73(4):617-22.
8
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.使用选择性缺乏促进因子VII激活能力的组织因子突变体对血浆中活化因子VII水平进行定量分析。
Blood. 1993 Feb 1;81(3):734-44.
9
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.冠状动脉疾病中的活化及总凝血因子VII和纤维蛋白原。
Scand Cardiovasc J. 1998;32(2):87-95. doi: 10.1080/14017439850140238.
10
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.凝血因子VII、R353Q多态性与冠心病高危男性血清含胆碱磷脂的关系
Thromb Res. 2004;113(1):57-65. doi: 10.1016/j.thromres.2004.02.001.

引用本文的文献

1
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.凝血因子 VII 的生化、分子和临床方面及其在止血和血栓形成中的作用。
Haematologica. 2021 Feb 1;106(2):351-362. doi: 10.3324/haematol.2020.248542.
2
Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.日本人群中凝血因子VII与心肌梗死发病率:自治医科大学队列研究
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22133. Epub 2017 Feb 13.
3
The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol.
肿瘤坏死因子-α或异丙肾上腺素可增强脂肪细胞中凝血因子VII的产生。
Int J Obes (Lond). 2015 May;39(5):747-54. doi: 10.1038/ijo.2014.208. Epub 2014 Dec 15.
4
Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor.从华法林切换至利伐沙班(一种口服、直接的 Xa 因子抑制剂)的药物剂量调整方案的计算研究。
Front Physiol. 2014 Nov 7;5:417. doi: 10.3389/fphys.2014.00417. eCollection 2014.
5
Role of coagulation factor VII in pathogenesis of ischemic heart disease.凝血因子VII在缺血性心脏病发病机制中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2006;26(6):657-60. doi: 10.1007/s11596-006-0607-3.
6
Is activated factor VII associated with retinal vein occlusion?活化因子VII与视网膜静脉阻塞有关吗?
Br J Ophthalmol. 2001 Oct;85(10):1174-8. doi: 10.1136/bjo.85.10.1174.